Navigation Links
Elusys' Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection
Date:4/22/2008

ntures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
2. Special coating greatly improves solar cell performance
3. Method to deliver molecules within embryonic stem cells improves differentiation
4. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
5. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
6. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
7. Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
8. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
9. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
10. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
11. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... LIBREVILLE, Gabon, December 2 ...Everyone,s Problem and Heritage" , Coinci...2-3 June 2010 the,Gabonese Republic is hosting an ...the issue of safeguarding biological resources in ...ent and state leaders, ministers,scientific exper...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte ...l oral JAK2 inhibitor, SB1518, at The American Soc...ion in New Orleans. ,, Data will be presented o...ation trial of SB1518 detailing its safety, tolera... profile in dose levels ranging from 100 to 600 mg...
(Date:12/2/2009)..., SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The w... are in turmoil and uncertainty is part of many,bu...rma industry has been,relatively immune to the eco...ation. , During the midst of the difficul...n & Johnson inaugurated an R&D center in S...
(Date:12/1/2009)...NCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall...day announced revenue guidance for the fourth quar...illion, as compared with $69 million for the fourt... results was the first of two installment payments...fourth quarter 2008 results was a one-time $1.8 mi...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...urogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutic...ng novel pain management therapies, today announce...7, 2009 at 4:30 p.m. ET (1:30 p.m. PT) to report r...rence call will be hosted by Anthony DiTonno, Pres...glieri, Chief Financial Officer. , , To particip...
...maceuticals, Inc. (Nasdaq: TRBN ) today announce...first quarter ended March 31, 2009, after the clos... conference call will take place May 7, 2009, at 2...ewscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , ...n Trubion,s website at http://investors.trubion...
...chTechnology, Inc. (ERT), (Nasdaq: ERES ), a lea...logy, ePRO and other services to the biopharmaceut...unced today results for the first quarter of 2009....refer to changes from the same period a year ago. ... , Quarterly net revenue was $23.8 million ...
Other Biology Technology:NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results 2NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results 3Trubion Announces Dates for First-Quarter 2009 Earnings Conference Call 2ERT Reports First Quarter 2009 Results 2ERT Reports First Quarter 2009 Results 3ERT Reports First Quarter 2009 Results 4ERT Reports First Quarter 2009 Results 5ERT Reports First Quarter 2009 Results 6ERT Reports First Quarter 2009 Results 7ERT Reports First Quarter 2009 Results 8ERT Reports First Quarter 2009 Results 9
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
(Date:12/1/2009)...COLUMBUS, Ohio Ohio State University cancer resea...t both kills brain-tumor cells and blocks the grow...shows that viruses designed to kill cancer cells ... aggressive brain tumors if they also carry a gene..., The protein, called vasculostatin, is normally ...
(Date:12/1/2009)...Yehezkel Ben-Ari, winner of the 2009 Inserm Grand ...d its commitment to paying tribute to outstanding,...s. By honouring talents, Inserm intends to,demons...ved in today,s biological, medical and,health res...nd women who carry out and,drive this research ea...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Tumor-attacking virus strikes with 'one-two punch' 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Narconon Centers Educate Thousands During Red Ribbon Week 60796 1Narconon Centers Educate Thousands During Red Ribbon Week 60796 2Colorado Companies Team Up With U S Fish 26amp 3B Wildlife Service to Protect Black Footed Ferret 14744 1Colorado Companies Team Up With U S Fish 26amp 3B Wildlife Service to Protect Black Footed Ferret 14744 2Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 1Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 2Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 3Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 4Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 5Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 6
... Neuroscience and Ophthalmology at LSU Health Sci...paper identifying, for the first time, a specific ...once thought to be no more than a byproduct, in re...imer,s disease. The paper, An NF-kB-sensitive micr...mer,s disease and in stressed human brain cells, w...
...re and University of St Andrews has identified a k... into a close relative in Britain, showing how gen...or evolution. , The researchers unravelled the r...e relative of the common British weed Groundsel, t...an amazing piece of genetic detective work, to be ...
...covered in the open ocean may force scientists to ...ogen cycle through ocean ecosystems. A research te...es at the University of California, Santa Cruz, ch...ic material, even though researchers have not been...the newly described organism seems to be an atypic...
Other Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3
... Sequi-Gen GT and PowerPac 3000 system, 220-240 V,...50 cm vertical slab gel format. The system include...hich is capable of separating nucleic acids with s...l plate chamber (IPC) assembly (IPC and bonded inn...
PowerPac HV Power Supply With Temperature Probe from Bio-Rad
Super Cooling Coil, Trans-Blot cell from Bio-Rad
...incorporating a wide range of next-generation feat... a new standard for flexible laboratory solutions....g pipetting, dilution, dispensing, and integration...ul and flexible as it is efficient and economical....
Biology Products: